Results 11 to 20 of about 104,967 (312)
NiO nanoparticles were administered to rat lungs via intratracheal instillation or inhalation. During pulmonary toxicity caused by NiO nanoparticles, the induction of oxidative stress is a major factor.
Masanori Horie +10 more
doaj +1 more source
The increased prevalence of pulmonary methicillin-resistant Staphylococcus aureus (MRSA) infection in patients living with cystic fibrosis (CF) is concerning due to a correlation with reduced life expectancy and lack of available treatment options.
Donna M. Konicek +12 more
doaj +1 more source
Pulmonary talcosis related to cocaine inhalation [PDF]
Tatiana Almeida Gonçalves +2 more
doaj +4 more sources
Pulmonary Delivery of Inhalable Nanoparticles: Dry Powder Inhalers
Pulmonary administration of inhalable nanoparticles (NPs) is an emerging area of interest. Dry powder inhalers may offer particular advantages for pulmonary administration of NPs. This article reviews research performed on the formulation of inhalable NPs as dry powder to achieve deep-lung deposition and enhance NP redispersibility.
M H D Kamal, Al-Hallak +5 more
openaire +5 more sources
Respimat as the new standard for inhalation therapy devices
The effectiveness of inhalation therapy can be significantly reduced by a number of problems. For example, inhalation technique errors can reduce the dose delivered by 22-95% compared to the optimal value in patients with technical errors in the use of ...
V. V. Arkhipov
doaj +1 more source
Inhaled iloprost efficiently improves pulmonary hemodynamics, exercise capacity, and quality of life in patients with pulmonary arterial hypertension (PAH). However, the process of inhalation is laborious for patients suffering from resting dyspnea.
Kazuhiko Nakayama +11 more
doaj +1 more source
PULMONARY COMPLICATIONS FOLLOWING SMOKE INHALATION
Two patients with severe respiratory disturbance following burning accidents are described. It is suggested that smoke inhalation injuries may in future present a more frequent problem in the intensive therapy unit, and the mechanisms of the disorder and its treatment are discussed.
C S, McArdle, W E, Finlay
openaire +2 more sources
In the treatment of pulmonary diseases the inhalation of aerosols plays a key role - it is the preferred route of drug delivery in asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis.
Fischer A +3 more
doaj +1 more source
Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes
The inhalation route is frequently used to administer drugs for the management of respiratory diseases such as asthma or chronic obstructive pulmonary disease.
Jens Markus Borghardt +2 more
doaj +1 more source
Introduction: Chronic obstructive pulmonary disease and asthma affect almost 300 million individuals. Inhaled therapy is often associated with technical errors reducing efficacy and compliance.
Tiago Maricoto +5 more
doaj +1 more source

